TachoSil Unión Europea - húngaro - EMA (European Medicines Agency)

tachosil

corza medical gmbh - humán fibrinogén, humán trombin - hemosztázis, sebészeti - antihaemorrhagiás - tachosil is indicated in adults and children from 1 month of age for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for suture support in vascular surgery where standard techniques are insufficient. tachosil is indicated in adults for supportive sealing of the dura mater to prevent postoperative cerebrospinal leakage following neurological surgery (see section 5.

Teysuno Unión Europea - húngaro - EMA (European Medicines Agency)

teysuno

nordic group b.v. - tegafur, gimeracil, oteracil - gyomor-daganatok - daganatellenes szerek - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Velphoro Unión Europea - húngaro - EMA (European Medicines Agency)

velphoro

vifor fresenius medical care renal pharma france - sucroferric oxyhydroxide - hyperphosphatemia; renal dialysis - gyógyszerek kezelés, hyperkalaemia, hyperphosphatemia - velphoro javallt az irányítást a foszfor szérum felnőtt krónikus vese betegség (ckd) beteg hemodialízis (hd) vagy a peritoneális dialízis (pd). velphoro is indicated for the control of serum phosphorus levels in paediatric patients 2 years of age and older with ckd stages 4-5 (defined by a glomerular filtration rate.